Karyopharm Therapeutics Inc

24 sept. 2026, 21:30 UTC

Karyopharm Therapeutics Inc saw a significant rise in after-market trading on Thursday, peaking well above its previous close before slightly retracing.

23 sept. 2026, 20:07 UTC

Karyopharm Therapeutics Inc shares fell sharply amid broader market pressure, continuing a decline since Tuesday's close, despite a slight recovery earlier in the session.

22 sept. 2026, 20:07 UTC

Karyopharm Therapeutics Inc shares fell, reflecting broader market declines, after an earlier rebound from a session low. The stock remains above its 20-day moving average.

21 sept. 2026, 20:01 UTC

Karyopharm Therapeutics Inc is rising, trading above its 20-day moving average and extending a trend of four consecutive sessions closing higher.

18 sept. 2026, 20:02 UTC

Karyopharm Therapeutics Inc is sharply higher in Friday's trading session, despite currently trading lower and diverging from recent upward momentum.

17 sept. 2026, 20:07 UTC

Karyopharm Therapeutics Inc is gaining during Thursday's trading, advancing significantly since Wednesday's close and peaking near the session's end.

16 sept. 2026, 19:43 UTC

Karyopharm Therapeutics Inc is trading sharply higher, reaching a peak this morning before slightly retracing, but remains below its 20-day moving average.

15 sept. 2026, 19:53 UTC

Karyopharm Therapeutics Inc shares are lower amid broader market declines and investor concerns over anticipated Federal Reserve rate hikes and geopolitical tensions.

11 sept. 2026, 20:01 UTC

Karyopharm Therapeutics has entered a Forbearance Agreement, trading lower as it faces a $15.8 million principal payment due and $20 million in fees.

10 sept. 2026, 20:07 UTC

Karyopharm Therapeutics is lower today, continuing a broader trend of weakness and remaining below its 20-day moving average. No specific news was identified.

8 sept. 2026, 20:07 UTC

Karyopharm Therapeutics shares are lower after downgrades from Robert W. Baird and HC Wainwright, with a target price set at $3.00.

2 sept. 2026, 20:08 UTC

Karyopharm Therapeutics Inc shares are lower today, having reached a session low earlier. The stock remains near the lower end of its one-month range.

1 sept. 2026, 20:01 UTC

Karyopharm Therapeutics submitted a supplemental New Drug Application for XPOVIO, but shares are trading lower amid broader market concerns about rising oil prices and interest rates.

31 août 2026, 20:02 UTC

Karyopharm Therapeutics submitted a supplemental New Drug Application for XPOVIO, seeking Accelerated Approval for myelofibrosis treatment. Shares are gaining during Monday's session.

28 août 2026, 20:08 UTC

Karyopharm Therapeutics Inc shares declined during Friday's session amid rising U.S. Treasury yields, reflecting broader market trends. The stock finished near its one-month low.

25 août 2026, 20:07 UTC

Karyopharm Therapeutics Inc shares are higher during Tuesday's session, reaching a peak earlier in the day. The stock remains below its 20-day moving average.

24 août 2026, 19:16 UTC

Karyopharm Therapeutics Inc shares are lower today, reaching a session low amid ongoing market weakness and no specific news to explain the decline.

21 août 2026, 23:51 UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours, following a brief uptick earlier. No specific news was identified to explain the decline.

20 août 2026, 20:02 UTC

Karyopharm Therapeutics is declining sharply amid a significant downturn in the Biotechnology sub-sector, nearing the lower end of its one-month trading range.

18 août 2026, 20:03 UTC

Karyopharm Therapeutics Inc is trading higher today, continuing its upward trend since Monday's close. The stock remains below its 20-day moving average.

17 août 2026, 23:46 UTC

Karyopharm Therapeutics shares are higher in after-market hours, following volatility earlier. Broader market pressures include geopolitical tensions and rising crude oil prices.

14 août 2026, 23:51 UTC

Karyopharm Therapeutics shares are higher in after-market trading, despite no specific news. Broader market sentiment reflects concerns from a decline in U.S. retail sales.

13 août 2026, 23:11 UTC

Karyopharm Therapeutics Inc shares are rising in after-market trading, showing a modest upward trend since Thursday's close despite recent significant declines.

12 août 2026, 19:56 UTC

Karyopharm Therapeutics Inc shares are lower today, retracing from an early high amid broader market conditions and geopolitical tensions. No specific news was identified.

11 août 2026, 20:01 UTC

Karyopharm Therapeutics Inc is trading higher today, having reached a peak earlier in the session. The stock remains below its 20-day moving average.

10 août 2026, 20:06 UTC

Karyopharm Therapeutics Inc shares are lower today, reversing an early gain and reaching a mid-morning low, with no specific news identified for the decline.

7 août 2026, 23:31 UTC

Karyopharm Therapeutics shares are lower in after-market hours, following a decline earlier despite gains in major tech stocks. No specific news was identified.

6 août 2026, 23:21 UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours. The asset is trading below its 20-day moving average and near the lower end of its one-month range.

5 août 2026, 23:01 UTC

Karyopharm Therapeutics shares are lower in after-market hours, continuing a three-session decline amid broader market weakness from disappointing U.S. employment data.

4 août 2026, 23:46 UTC

Karyopharm Therapeutics shares are higher in after-market trading, though no specific news explains the movement. Broader market optimism may be influencing risk assets.